IRadimed Q3 Non-GAAP Earnings, Revenue Increase; Q4 Outlook Issued, 2026 Guidance Revised

09:20 AM EDT, 10/30/2026 (MT Newswires) -- IRadimed (IRMD) reported Q3 non-GAAP earnings Friday of $0.55 per diluted share, up from $0.47 a year earlier. An analyst polled by FactSet expected $0.55. Revenue for the quarter ended Sept. 30 was $24.2 million, up from $21.2 million a year earlier. Three analysts expected $23.5 million. For Q4, the company expects non-GAAP diluted EPS of $0.57 to $0.61, and revenue of $25.0 million to $26.5 million. Three analysts expect $0.63 and $26.2 million, respectively. For 2026, the company now expects non-GAAP diluted EPS to be between $2.07 and $2.11, compared with previous guidance of $2.06 to $2.21, according to Chief Executive Roger Susi. Three analysts expect $2.11. The company narrowed its revenue range to between $91.6 million and $93.1 million, compared with $91.0 million to $96 million previously. Three analysts expect $92.1 million.